Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.2143
+0.00341.61%
Volume:1.22M
Turnover:264.74K
Market Cap:11.96M
PE:-0.33
High:0.2317
Open:0.2100
Low:0.2060
Close:0.2109
52wk High:1.55
52wk Low:0.1952
Shares:55.82M
Float Shares:54.40M
Volume Ratio:1.26
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6401
EPS(LYR):-0.7437
ROE:-543.97%
ROA:-70.59%
PB:-3.34
PE(LYR):-0.29

Loading ...

PDS Biotech Removes COO Stephan Toutain Without Cause

Reuters
·
Aug 26

PDS Biotechnology Corp - on Aug 6, Approved Reduction in Force to Align Expenses with Strategic Priorities - SEC Filing

THOMSON REUTERS
·
Aug 26

PDS Biotechnology Corp - Stephan Toutain Removed as Chief Operating Officer Effective August 21, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 26

PDS Biotechnology Says Lars Boesgaard to Resign as CFO Effective September 12

Reuters
·
Aug 20

PDS Biotechnology - Lars Boesgaard to Resign as CFO, Principal Financial Officer & Principal Accounting Officer Effective Sept 12- SEC Filing

THOMSON REUTERS
·
Aug 20

PDS Biotech Names Controller Janetta Trochimiuk Interim Principal Accounting Officer as CFO Resigns

Reuters
·
Aug 20

PDS Biotech Holds Annual Shareholder Meeting, Quorum Reached

Reuters
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

PDS Biotechnology Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

PDS Biotech Q2 FY26 Net Loss Widens to $9.8 Million; R&D Expense Falls 22.49% to $3.3 Million

Reuters
·
Aug 13

PDS Biotech Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 13

PDS Biotechnology Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 13

PDS Biotech Publishes Shareholder Letter on Strategic Refocus to Pds0301

Reuters
·
Aug 11

PDS Biotech to Report Quarterly Financial Results

Reuters
·
Aug 11

PDS Biotechnology Corp - Biotech Discontinues Internal Investment in Pds0101 Phase 3 Versatile-003 Trial

THOMSON REUTERS
·
Aug 11

PDS Biotech Announces Strategic Refocus Prioritizing Pds0301 in Metastatic Colorectal Cancer (Mcrc) and Partnership Strategy for Pds0101

THOMSON REUTERS
·
Aug 11

PDS Biotechnology Corp Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Aug 08

PDS Biotech Gets NASDAQ Notice After Shares Trade Below $1 Bid-price Minimum

Reuters
·
Aug 01

New Issue 104 X Trading Warrants Issue Date 29 Jul 26 Pds-ctw

Reuters
·
Jul 28